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Abstract 
Alzheimer’s disease (AD) is heritable with complex genetic underpinnings. Based on 
previous results from large-scale genome-wide association studies (GWAS), recent 
studies found an association between the polygenic risk score (PGRS) of AD and the 
structure of some preselected brain regions, but the effects of AD PGRS on all voxels 
of the brain have not been fully investigated. In the current study, we examined the 
voxel-wise effect of AD PGRS on the entire brain and the influence of AD PGRS on 
cognitive function in two independent healthy young cohorts. In both cohorts, an 
elevated AD PGRS was associated with a smaller precuneal volume, and the effect 
remained after excluding the APOE genotype. No correlation was found between AD 
PGRS and any cognitive measure in either sample. Finding a negative correlation 
between the AD PGRS and the precuneal volume could help to elucidate the 
mechanism of the genetic risk for AD and could provide a potential biomarker for 
early detection and possible interventions in AD. 
 
Key words: Alzheimer’s disease; neuroimaging; polygenic risk score; precuneus 
 
1. Introduction 
As many as 60-70% of dementia patients have Alzheimer's disease (AD), making it 
the most common type of dementia (Duthey, 2013). Treatments to stop or reverse the 
progression of this disease are not yet available. With the proportion of people aged 
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60 and over increasing rapidly, the impact of AD on society and public health has 
caused extensive concern. 
 
The individual risk for AD has complex genetic underpinnings with a heritability 
estimate of 50-70% (Gatz et al., 1997; Pedersen et al., 2004). Genome-wide 
association studies (GWAS) identified several common risk variants for AD, but most 
of these risk alleles only showed a modest effect size (odds ratio [OR] ~ 0.86-1.22) 
(Lambert et al., 2013; Naj et al., 2011; Seshadri et al., 2010). Therefore, many studies 
used the polygenetic risk score (PGRS), which combines loci with low effects to 
identify phenotypic associations. The PGRS enables the identification of phenotypic 
associations which would not be detectable using single loci with low effect sizes and 
has been proposed to improve predictive ability and statistical power (Dima and 
Breen, 2015; Dudbridge, 2013). 
 
The AD PGRS has been found to be associated with the risk of familial late-onset AD 
(Tosto et al., 2017), accelerated progression from mild cognitive impairment (MCI) to 
AD (Rodriguez-Rodriguez et al., 2013), cognitive scores (Verhaaren et al., 2013), and 
neuroimaging measures, including total brain volume (Chauhan et al., 2015), 
hippocampal volume (Chauhan et al., 2015; Foley et al., 2017; Lupton et al., 2016; 
Mormino et al., 2016), the cortical thickness in AD-vulnerable regions (Sabuncu et al., 
2012), and the fractional anisotropy of the right cingulum (Foley et al., 2017). These 
studies, especially the neuroimaging studies, help to elucidate the mechanisms of the 
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genetic contribution to AD risk. However, only a few brain regions have been 
selected and studied based on a priori hypotheses, and the effects of the PGRS on all 
voxels of the brain remain unclear. In addition, any early voxel-wise effects of AD 
risk factors on the brains of healthy young adults before substantial age-related 
atrophy occurs needs to be clear, since AD pathology begins decades before clinical 
symptoms (Frisoni et al., 2010; Weiner et al., 2015) and because single genetic 
variants for AD risk have individually been shown to affect brain structure in young 
people (O'Dwyer et al., 2012) and infants (Dean et al., 2014). 
 
In the current study, we tested the joint effects of the cumulative AD risk variants on 
brain structure using a hypothesis-free voxel-wise approach in two independent young 
healthy samples. The PGRS was computed from the currently largest AD GWAS 
dataset, comprising 17,008 cases and 37,154 controls, obtained by the International 
Genomics of Alzheimer's Project (IGAP) (Lambert et al., 2013). We hypothesized 
that the AD PGRS would be linked to decreased brain volume in AD-vulnerable 
regions. 
 
2. Methods 
2.1. Participants 
The discovery dataset recruited a total of 360 healthy young Chinese subjects (174 
females, mean age = 19.4±1.1 years) (Li et al., 2015) who, together with their first-, 
second-, and third-degree relatives, had no history of psychiatric disorder. None of the 
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subjects had neurological disorders or were taking any medications that could 
interfere with their ability to complete the MRI scanning. They all gave informed 
written consent. This study was approved by the Ethics Committee of the School of 
Life Science and Technology at the University of Electronic Science and Technology 
of China.  
 
To validate the reliability of the polygenic effect on brain structure, we also recruited 
an independent dataset. The replication dataset was obtained from a different cohort 
of subjects and included a total of 323 healthy young Chinese participants (166 
females, mean age = 22.7±2.5 years) (Li et al., 2013). None of the subjects had any 
history of psychiatric diagnoses or of neurological illnesses. This study was approved 
by the Ethics Committee of Tianjin Medical University. All the subjects gave full 
written informed consent. 
 
2.2. Genotype Processing 
After a blood sample was collected, genomic DNA was extracted by using the 
E.Z.N.A.™ Blood DNA Kit (Omega Bio-Tek, Georgia, US). Next, Whole-genome 
genotyping was performed on Illumina Human OmniZhongHua-8 BeadChips 
(including 900,015 SNP markers and CNV probes) using the standard Illumina 
genotyping protocol (Illumina). Then the following genotype QCs were performed 
using PLINK 1.07 (Purcell et al., 2007): First, four individuals with missing genotype 
rates greater than 0.05 were removed (one from the discovery dataset and three from 
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the replication dataset). Subsequently, pairwise identity-by-descent (IBD) was 
estimated to find pairs of individuals who had more similar genotypes than expected 
by chance in a random sample, and seven subjects (two from the discovery and five 
from the replication datasets) were additionally removed as they were identified as 
having possible relative relationships with another person in the dataset and, of the 
pair, had the higher missing genotype rate. Then, SNP-level filtering was applied; 
SNPs that met one of the following criteria were removed: a minor allele frequency 
less than 0.01, missing genotype rates greater than 0.05, or significant departure from 
Hardy-Weinberg equilibrium (p < 0.001). To control for population stratification, a 
principal component analysis (PCA) was then conducted using EIGENSTRAT 5.0.2 
(Patterson et al., 2006; Price et al., 2006) on a linkage disequilibrium (LD) pruned set 
of autosomal SNPs with the HapMap phase 3 reference data set (Thorisson et al., 
2005); and five long-range LD regions were removed. Next, the outliers of the 
subjects in ten principal components (more than six standard deviations from the 
mean) were excluded. Ungenotyped SNPs were imputed using SHAPEIT v2 (r790) 
(Delaneau et al., 2011) and IMPUTE2 (Howie et al., 2009) with the 1000 Genomes 
Phase 1 reference dataset. Only imputed autosomal SNPs that had imputation quality 
scores greater than 0.8 were retained. After these QC procedures, a further analysis 
focused on a total of 357 (discovery dataset) and 315 (replication dataset) subjects 
with more than 7 million SNPs (see Table 1 for demographic details). We also 
defined the APOE score asε4/ε2 status (ε2/ε3 = 1, ε3/ε3 = 2, ε3/ε4 = 3) for the 
subsequent analyses. 
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2.3. Computation of the PGRS 
To compute the polygenic AD-risk score, we used the “score” utility in PLINK 
(Purcell et al., 2007) and the large meta-GWAS results (Lambert et al., 2013) reported 
by the International Genomics of Alzheimer’s project (IGAP). First, SNPs that 
showed a nominal association with AD (p < 0.05) from the GWAS results were 
selected. To account for only independent association signals, LD pruning was then 
conducted using the clumping utility in PLINK with an LD r2 < 0.25 within a 500 bp 
window, and the index SNPs were extracted using the most significant association 
p-value within each clumped region. The index SNP list was acquired and SNPs with 
a minor allele frequency < 0.01 in the target sample were further removed; the 
remained SNPs were used to calculate the PGRS. Finally, the polygenic scores were 
computed as the summation of an individual’s genotype across the obtained SNP list, 
which consisted of 60,263 independent SNPs weighted by the effect size estimated 
based on the IGAP GWAS (see Supplementary Table S1 for SNP information). An 
unweighted score was constructed by summing the number of AD-associated alleles 
across selected markers without considering their effect sizes.  
 
2.4. MRI Data Acquisition and Processing 
MRI scans for the two independent datasets were performed using the following 
parameters: in the discovery dataset, TR = 8.16 ms, TE = 3.18 ms, flip angle = 7°, 
FOV = 256 mm × 256 mm2, voxel size = 1 × 1 × 1 mm3, and 188 slices in an MR750 
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3.0 Tesla magnetic resonance scanner (GE Healthcare); in the replication dataset, TR 
= 8.1 ms, TE = 3.1 ms, flip angle = 13°, FOV = 256 × 256 mm2, voxel size = 1 × 1 × 
1 mm3, and 176 slices in a 3.0 T Signa HDx GE scanner. All the raw MRI data were 
then inspected by two experienced radiologists who were blind to the PGRS 
information. 
 
The structural MRI scans were processed using the Diffeomorphic Anatomical 
Registration Through the Exponentiated Lie Algebra (DARTEL) -based VBM 
(Ashburner, 2007) toolbox (http://dbm.neuro.uni-hen.de/vbm) in SPM8 (Wellcome 
Department of Imaging Neuroscience, London, UK, http://www.fil.ion.ucl.ac.uk/spm) 
executed in MATLAB 2013a (The MathWorks, Natick, MA). Following 
segmentation, gray matter (GM) templates were generated using the entire image 
dataset. The GM template was initially affine registered to the tissue probability map 
in Montreal Neurological Institute (MNI) space, and the GM images were 
non-linearly warped to the GM template in MNI space. The GM segments were 
modulated by using the affine and non-linear components, and the actual gray-matter 
values (modulated GM volumes) were generated locally. The modulated GM 
segments were then smoothed using a Gaussian kernel of 8 mm full width at half 
maximum. After these steps, we obtained the normalized, modulated, and smoothed 
gray-matter maps. The value of each voxel reflected the volume information with 
spatial deformation and was used for later statistical analyses. In addition, the gray 
matter, white matter, and CSF volumes in the native MRI brain scan for each subject 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT   
 10
were standard outputs; so an estimate of the total intracranial volume (eTIV) was 
calculated as the sum of the three volumes. Two of 315 subjects in the replication 
sample were excluded because of excessive head motion during the T1 scans. The 
final sample for the gene-brain analyses included 357 subjects in the discovery dataset 
and 313 individuals in the replication dataset. 
 
2.5. Cognitive Tests 
All subjects took the Chinese Revised Wechsler Adult Intelligence Scale (WAIS-RC) 
(Gong, 1982) and performed the working memory (WM) tasks with an N-back 
paradigm (2- and 3-back), as described in our previous study (Li et al., 2015). In brief, 
the participants were continuously presented with a series of letters and were asked to 
decide whether the letter presented on the screen was the same as the one presented 
two letters earlier (for the 2-back task) or the one presented three letters earlier (for 
the 3-back task). Both the 2-back and 3-back tasks consisted of 3 blocks of 30 trials 
each, and all six blocks were presented randomly to each subject. Before the 
experiment, the participants were given verbal instructions followed by one practice 
block for each task. They had to pass 70% of the trials before they could take the real 
tests. Both the IQ test and the WM tasks were performed on a computer in a quiet 
room outside the MRI scanner. 
 
2.6. Statistical Analysis 
The association between the PGRS and the gray matter volume was analyzed 
separately in 2 datasets using SPM8. In both samples, the correlation was tested using 
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voxel-wise multiple regression models with age, gender, and the eTIV as covariates. 
The statistical result of was corrected for multiple comparisons using the “AlphaSim” 
implementation in REST Toolkit (Song et al., 2011), which is based on the Monte 
Carlo simulation in AFNI (see the AlphaSim command description at 
http://afni.nimh.nih.gov/afni/doc/manual/AlphaSim) in the discovery dataset. 
Correlation was reported at p < 0.001 (uncorrected), cluster size > 50 for the 
replication dataset. Then the correlation between the PGRS and the three cognitive 
measures (IQ, WM 2-, and 3-back performance) was calculated using a regression 
analysis with gender and age as covariates for the 2 datasets separately. The 
regression analyses with cognitive performance were carried out in in IBM SPSS 
statistics 22 (IBM Corp., Armonk, NY) for Windows. 
 
3. Results 
3.1. Association between the PGRS and Brain Volume in the Discovery Dataset 
The whole-brain VBM analyses showed a significant negative correlation (corrected p 
< 0.05) between the PGRS and gray matter volume (GMV) in the left precuneus (peak 
MNI coordinates x = -12, y = −51, z = 58.5, 166 voxels, peak T = -4.01) and the right 
cingulate gyrus (peak MNI coordinates x = 6, y = 3, z = 33, 188 voxels, peak T = 
-3.81) and a significant positive correlation between the AD PGRS and the GMV in 
the right superior frontal gyrus (peak MNI coordinates x = 6, y = 66, z = 1.5, 472 
voxels, peak T = 4.48) and the right caudate (peak MNI coordinates x = −1.5, y = 4.5, 
z = 1.5, 418 voxels, peak T = 4.10) (Figure 1). This suggested that subjects in the 
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discovery set with a higher AD PGRS had a smaller GMV in the left precuneus and 
right cingulate gyrus and a larger GMV in the right superior frontal gyrus and right 
caudate.  
 
3.2. Association between the PGRS and the Brain Volume in the Replication Dataset 
Regression analysis between the PGRS and brain volume was carried out using a 
voxel-wise multiple regression model in the replication sample. Only the left 
precuneus (peak MNI coordinates x = −4.5, y = −72, z = 46.5, 90 voxels, peak T = 
-3.61) reached significance (uncorrected p < 0.001, k > 50) and showed a negative 
correlation with the PGRS (Figure 2). This supported the conclusion in the discovery 
dataset that subjects with a higher genetic risk for AD had a smaller gray matter 
volume in the precuneus. 
 
3.3. Association between the PGRS and the extracted precuneal volume in both 
datasets 
The left precuneus was found to be associated with the AD PGRS in both cohorts. 
Next, the average GMVs of the affected precuneus were extracted, and linear 
regressions with the PGRS as the predictor for the precuneal volume were carried out 
with age, gender, and eTIV as covariates. We found that the AD PGRS is 
significantly associated with the GMV of the precuneus (in the discovery dataset, T = 
-4.05, p = 6.36×10-5; in the replication dataset, T = -3.71, p = 2.48×10-4) (Figure 3). 
To determine whether the effect of the PGRS on the precuneal volume was 
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independent of the APOE genotype, the APOE genotype was added to the regression 
model as a covariate. The effect of the PGRS on the GMV of the precuneus remained 
significant (in the discovery dataset, T = -3.89, p = 1.22×10-4; in the replication 
dataset, T = -3.57, p = 4.16×10-4). These results suggested that the relationship 
between the AD PGRS and the precuneal volume is not exclusively affected by the 
APOE gene but by multiple genetic factors.  
 
To ensure that the association was not affected by education or population 
stratification, we also included years of education and the first ten principal 
components estimated from our GWAS data as covariates with age, gender, and eTIV 
in the regression model in both datasets. The results showed the association between 
the PGRS and the GMV of the precuneus remained significant (in the discovery 
dataset, T = -4.08, p = 5.52×10-5; in the replication dataset, T = -3.17, p = 1.71×10-3). 
 
Finally, we conducted analyses with an unweighted PGRS to ascertain whether the 
associations differed by weighting strategy. Linear regression analyses were 
conducted for the precuneal volume with the unweighted AD PGRS as predictors, 
with age, gender, years of education, eTIV and the first ten principal components 
estimated from our GWAS data as covariates in both datasets, separately. These 
results showed that the association between the unweighted AD PGRS and the 
precuneal volume was significant only in the discovery dataset (in the discovery 
dataset, T = -2.16, p = 0.031; in the replication dataset, T = -1.21, p = 0.23). Then a 
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fixed-effect meta-analysis based on these results was performed. We found a 
significant negative association between the unweighted AD PGRS and the precuneal 
volume (pooled beta = -0.083, 95% CI: –0.15 to -0.015, p = 0.016; Figure S1). 
 
3.4. Association between the PGRS and Cognitive Measures in Both Datasets 
To test the effect of polygenic risk for AD on cognitive function, regression analyses 
were carried out for both cohorts. No associations were found between the AD PGRS 
and cognitive variables (IQ or working memory 2- and 3-back) (all ps > 0.05; Table 2) 
in either the discovery or the replication dataset. Then years of education and the first 
ten principal components estimated from our GWAS data were added as covariates in 
the regression model in both datasets, no associations were found between the AD 
PGRS and cognitive variables (IQ or working memory 2- and 3-back) (all ps > 0.05; 
Supplementary Table S2) in either dataset. 
 
4. Discussion 
By combining structural MRI and genome-wide genetic data from two independent 
young cohorts, we found a consistent negative correlation between the AD PGRS and 
the left precuneal volume, a brain region which is preferentially vulnerable to AD 
(Ryu et al., 2010; Sperling et al., 2009). This suggested an effect of AD PGRS on 
brain structure several decades before any possible clinical symptoms of AD could 
develop and may provide implications for the genetic mechanisms underlying AD 
pathology. 
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Several studies have examined the influence of the AD PGRS on brain structure. 
These studies tested the association between the polygenic risk for AD and 
hippocampal volume and found this association in a large population-based 
meta-analysis in healthy older adults and MCI subjects (Lupton et al., 2016; Mormino 
et al., 2016) . This association was validated in one young cohort (Foley et al., 2017) 
but not in another young sample (Lupton et al., 2016). The effect of the AD PGRS on 
the cortical thickness of some AD-vulnerable regions in healthy older (Sabuncu et al., 
2012) and young individuals (Foley et al., 2017), on the fractional anisotropy of the 
right cingulum in healthy young adults (Foley et al., 2017), and on total brain volume 
in dementia-free participants (Chauhan et al., 2015) were also reported. These studies 
confirmed the influence of the polygenic risk for AD on some MRI-based 
intermediate phenotypes of AD in the general population. However, these studies all 
focused only on preselected regions, while possible structural changes in other areas 
remained unknown. In addition, they could not tell us at what age the influences of 
the AD PGRS on the entire brain structure initially manifest. The current study used a 
hypothesis-free VBM analysis, which has been widely used to detect structural 
atrophy in individuals with AD (Shimoda et al., 2015; Whitwell et al., 2008), to 
estimate the effect of the AD PGRS on voxel-wise anatomical differences by 
exploring the whole brain. Using this data-driven approach, we showed that the AD 
PGRS seems to have influenced the volume of several cortical structures that had not 
been reported in previous ROI studies. Additionally, by recruiting young samples, we 
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also found that these AD-related brain structures were modulated by the polygenic 
risk for AD even in young adults. 
 
One especially interesting finding of our study was the negative association between 
the AD PGRS and the left precuneal volume in both datasets. This was expected 
because the precuneus is a pivotal region for the disease process of AD. The 
precuneus is preferentially affected pathologically (Sperling et al., 2009), structurally 
(Ryu et al., 2010), and functionally (Sadigh-Eteghad et al., 2014) in AD. Compared 
with controls, AD patients exhibit significant atrophy (Migliaccio et al., 2009; Ryu et 
al., 2010) and a greater progressive volume change (Scheinin et al., 2009) in the 
precuneus. Other studies also observed decreased glucose metabolism (Pascual et al., 
2010) and hypoperfusion (Hu et al., 2010) in the precuneus and reduced functional 
connectivity between the precuneus and other AD vulnerable regions (Kim et al., 
2013) in AD patients compared to controls. In addition, structural features of the 
precuneus are one of the key biomarkers for optimizing the classification of MCI 
subjects into those who will convert to AD and those who will remain stable 
(Whitwell et al., 2008; Zhuang et al., 2012) and for discriminating between AD and 
frontotemporal lobar degeneration (McMillan et al., 2012). Moreover, studies have 
consistently found a significantly lower gray matter volume of the precuneus in 
subjects who were symptomatic familial Alzheimer disease mutation carriers (Cash et 
al., 2013), in cognitively healthy individuals with a family history of AD (Honea et al., 
2010), and even in infant carriers of AD genetic risk (APOE e4) (Dean et al., 2014). 
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Our results are in line with those from these studies, and together they suggest that the 
structure of the precuneus can be used as a preferred endophenotype for imaging 
genetics studies of the polygenic risk for AD.  
 
Many brain regions that have previously been reported to be affected in AD were not 
associated with the AD PGRS in the current study. One possible explanation is that 
the genetic risk of AD may impact those brain regions in older subjects (used in most 
previous studies) but not in young adults. We were not surprised at this negative result 
in our sample, as several studies have reported no association between the genetic risk 
of AD and the structure of brain regions affected in AD in young subjects (Lupton et 
al., 2016; Richter-Schmidinger et al., 2011). Moreover, smaller precuneal volume was 
reported in infant APOE ε4 carriers (Dean et al., 2014), indicating that the alteration 
of the precuneal structure is an early effect of the genetic predisposition for AD. 
Another potential reason is a lack of power in the current study. Using the 
AVENGEME package (Palla and Dudbridge, 2015), we calculated the power and 
found that we had 80% power to detect an effect ranging from 0.0215 to 0.0245 of the 
explained variance in our samples (N = 313-357). Give the effect sizes/explained 
variance of the PGRS calculated by previous studies about other AD related brain 
regions in young adults (Lupton et al., 2016), this study did not have sufficient power 
to determine small effect sizes of AD PGRS on those brain regions. Therefore, to 
obtain confirmatory evidence, future studies in samples with different age groups and 
with larger sample sizes are needed to test this association. 
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No effect of AD PGRS on cognitive performance was observed in our study. Previous 
studies of older subjects found that an elevated AD PGRS was associated with 
worse memory at baseline (Mormino et al., 2016) and with greater longitudinal 
cognitive decline over time (Louwersheimer et al., 2016). Age differences may 
explain the lack of a significant association between AD genetic risk and the cognitive 
measures in the current study. These results together suggested that the polygenic risk 
of AD influence AD-vulnerable brain regions decades before cognitive impairments 
can be detected. This may further indicate that brain volume is a more sensitive 
imaging marker for AD genetic risk than the cognitive measures tested here. 
 
There are several limitations: First of all, we calculated the AD PGRS for two Han 
Chinese samples using the GWAS result from Caucasian samples due to the lack of 
GWA study on Han Chinese samples, and to our knowledge, this is currently the 
largest AD GWAS dataset. In our analysis, we considered both weighted and 
unweighted risk scores to ensure that the use of Caucasian-derived SNPs weights did 
not affect the results. We found a consistent negative association between the AD 
PGRS and the precuneal volume using either a weighting or an unweighting strategy. 
Several studies have reported that the genetic risk score based on one ethnic 
population can translate to other ethnic groups (Domingue et al., 2014; Ikeda et al., 
2011; Marden et al., 2014). These studies expanded the scope of the research to other 
populations and indicated that the PGRS is a useful approach for trans-ethnic 
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replication of genetic associations. Overall, our study generalized observations of a 
genetic basis for AD to populations with a different ethnicity. Further studies are 
needed to recalculate the AD PGRS once GWAS studies on Han Chinese samples are 
available. Besides, studies with larger populations to increase the statistical power and 
new approaches to increase the accuracy of the PGRS analysis in diverse populations 
are required (Marquez-Luna et al., 2017). 
 
Second, the current study used a conservative significance threshold (AlphaSim p 
<0.05 in the discovery sample and uncorrected p < 0.001 in the replicate sample), but 
this may not be sufficient. Regardless, given the exploratory nature of the study, it is 
plausible to use a permissive approach to avoid rejecting possibly interesting results. 
Further studies are needed to confirm these results. Third, although the precuneal 
regions extracted from the discovery sample and from the replication sample did not 
completely overlap, they consistently demonstrated a negative association between 
the polygenic risk for AD and the volume in the precuneal region and could help us 
understand the neurodegenerative process decades before the onset of clinical 
symptoms of AD. More evidence and replication studies are therefore needed. Fourth, 
how these brain measures change with age is unknown. Therefore, longitudinal 
studies are needed to follow healthy young adults over ten or more years to determine 
whether the decreased precuneal volume is followed by a higher risk of developing 
later pathological changes. 
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In summary, we showed that the AD polygenic score was associated with reduced 
volume in the left precuneus in two young, healthy groups. This association provides 
a mechanism for vulnerability to AD progression in people with a higher genetic risk 
for AD. These results also suggest that precuneal morphology might be an early 
biomarker for the prediction and possible prevention and treatment of AD. 
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Tables 
 
Table 1. Demographic characteristics of the participants 
 Discovery dataset Replication dataset 
Subjects 357 315 
Sex (male/female) 183:174 154:161 
Age (y) 19.41 ± 1.17 22.73 ± 2.48 
Age range (y) 18-24 18-31 
Values denote mean±standard deviation or number of subjects. 
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Table 2. Regression analyses between the AD PGRS and cognitive characteristics 
 
 
  
 Beta se T p 
Discovery dataset (n = 357) 
 IQ -0.011 0.049 -0.233 0.816 
 Working memory 2-back -0.068 0.053 -1.294 0.196 
 Working memory 3-back -0.061 0.053 -1.155 0.249 
Replication dataset (n = 315) 
 IQ -0.015 0.056 -0.274 0.784 
 Working memory 2-back 0.008 0.056 0.149 0.882 
 Working memory 3-back 0.001 0.057 0.019 0.985 
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Figures legends 
Figure 1  
 
Regions showing a significant association between GMV and AD PGRS in the 
discovery dataset. Whole-brain voxel-based morphometry showed that the AD 
PGRS score showed a significantly positive correlation with the right caudate and 
right superior frontal gyrus and a significantly negative correlation with the right 
cingulate gyrus and left precuneus (AlphaSim corrected p < 0.05, using a voxel-level 
threshold of uncorrected p < 0.001 and a cluster threshold of k > 143 voxels). 
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Figure 2  
 
The left precuneus showed a significant association between GMV and AD 
PGRS in both datasets. Whole-brain voxel-based morphometry showed that the AD 
PGRS score was significantly negatively correlated with a region in the left precuneus 
in (a) the discovery (AlphaSim corrected p < 0.05, using a voxel-level threshold of p 
< 0.001 and a cluster threshold of k > 143 voxels) and (b) the replication (using a 
voxel-level threshold of p < 0.001 and a cluster threshold of k > 50 voxels) datasets. 
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Figure 3  
 
Individual AD PGRS and GMV in the left affected precuneus in both datasets. 
Extracted individual gray-matter volume in the affected left precuneus was 
significantly negatively associated with the PGRS for AD in both (a) the discovery 
dataset and (b) the replication dataset. 
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Highlights 
The effect of Alzheimer’s disease (AD) polygenic score (PGRS) on brain structure 
was investigated with a hypotheses-free method. 
 
The precuneal volume is mediated by the genetic risk of AD in two independent 
cohorts.  
 
AD PGRS modulates the precuneal structure decades before any clinical expression 
of AD. 
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